A. Clemens

First name
A.
Last name
Clemens
Gallagher, A. M., Setakis, E., Plumb, J. M., Clemens, A., & van Staa, T. P. (2011). Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. http://doi.org/10.1160/th11-05-0353
View
Gallagher, A. M., de Vries, F., Plumb, J. M., Hass, B., Clemens, A., & van Staa, T. P. (2012). Quality of INR control and outcomes following venous thromboembolism. Clin Appl Thromb Hemost. http://doi.org/10.1177/1076029611426139
View
Lee, S., Monz, B. U., Clemens, A., Brueckmann, M., & . Y. Lip, G. (2012). Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database. BMJ Open. http://doi.org/10.1136/bmjopen-2012-001768
View
Gallagher, A. M., van Staa, T. P., Murray-Thomas, T., Schoof, N., Clemens, A., Ackermann, D., & Bartels, D. B. (2014). Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. http://doi.org/10.1136/bmjopen-2013-003839
View
Stolz, D., Kostikas, K., Loefroth, E., Fogel, R., Clemens, A., Gutzwiller, F. S., et al. (2017). Gender differences in COPD exacerbations: Analysis from the CPRD database. Thorax.
View
Stolz, D., Kostikas, K., Loefroth, E., Fogel, R., Gutzwiller, F. S., Conti, V., et al. (2019). Differences in COPD exacerbation risk between women and men: analysis from the UK Clinical Practice Research Datalink data. Chest. http://doi.org/10.1016/j.chest.2019.04.107
View
Kostikas, K., Price, D., Gutzwiller, F. S., Jones, B., Loefroth, E., Clemens, A., et al. (2020). Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s255414
View